Analyzing the distribution of virulence factors of <i>Mycobacterium tuberculosis</i> and the impact of virulence gene mutations on treatment outcomes in different lineages using whole-genome sequencing in Urumqi

This study centers on Urumqi, utilizing whole-genome sequencing and comparative genomics, we explored virulence factor mutations in different <i>Mycobacterium tuberculosis</i> lineages and their impact on tuberculosis patient prognosis. We utilized routine national drug resistance surveillance data from Urumqi, gathering demographic, epidemiological, and clinical data of patients with tuberculosis between 1 January 2017 to 31 December 2021. Whole-genome sequencing was employed, followed by bioinformatics analysis using various methods and statistical models. A total of 457 patients with tuberculosis were analyzed. Through whole-genome sequencing and bioinformatics analysis, we categorized these strains into three lineages: Lineage2 (347), Lineage3 (37), and Lineage4 (73), identifying 71 virulence factor mutations. The mutation rates of virulence factors in <i>M. tuberculosis</i> exhibited polarization. Significant differences in virulence factor mutation rates were observed among different <i>M. tuberculosis</i> lineages (all <i>p</i> values < 0.05). Additionally, mutations in espE, fadE29, and mbtI genes among Lineage2 patients were considered as risk factors influencing treatment outcomes (all <i>p</i> values < 0.05), with odds ratios of 13.6200 (1.7285-107.3201), 7.1262 (1.3294-38.1997), and 14.8340 (1.1577-190.0784), respectively. Varied virulence factor mutations and virulence factor-related gene mutations exist across different <i>M. tuberculosis</i> lineages. Mutations in the espE, fadE29, and mbtI genes are risk factors that significantly affect the treatment outcome of Lineage2 patients. This finding serves as a reference for investigating the future evolutionary direction, transmissibility, drug resistance, and pathogenicity of <i>M. tuberculosis</i> virulence factors in regions with diverse lineages and frequent population movements.

Authors

Institutions

Publication Details

Journal
Virulence
Published
2025-09-16
DOI
https://doi.org/10.1080/21505594.2025.2552875
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analyzing the distribution of virulence factors of Mycobacterium tuberculosis and the impact of virulence gene mutations on treatment outcomes in different lineages using whole-genome sequencing in Urumqi

Yaoqin Lu, Yanggui Chen, Chao Wang, Kai Wang et al.
Virulence
Tuberculosis Research and Epidemiology
article

Analyzing the distribution of virulence factors of Mycobacterium tuberculosis and the impact of virulence gene mutations on treatment outcomes in different lineages using whole-genome sequencing in Urumqi

Yaoqin Lu, Yanggui Chen, Chao Wang, Kai Wang, Jiandong Yang, Yida Wang
article en

Abstract

This study centers on Urumqi, utilizing whole-genome sequencing and comparative genomics, we explored virulence factor mutations in different <i>Mycobacterium tuberculosis</i> lineages and their impact on tuberculosis patient prognosis. We utilized routine national drug resistance surveillance data from Urumqi, gathering demographic, epidemiological, and clinical data of patients with tuberculosis between 1 January 2017 to 31 December 2021. Whole-genome sequencing was employed, followed by bioinformatics analysis using various methods and statistical models. A total of 457 patients with tuberculosis were analyzed. Through whole-genome sequencing and bioinformatics analysis, we categorized these strains into three lineages: Lineage2 (347), Lineage3 (37), and Lineage4 (73), identifying 71 virulence factor mutations. The mutation rates of virulence factors in <i>M. tuberculosis</i> exhibited polarization. Significant differences in virulence factor mutation rates were observed among different <i>M. tuberculosis</i> lineages (all <i>p</i> values < 0.05). Additionally, mutations in espE, fadE29, and mbtI genes among Lineage2 patients were considered as risk factors influencing treatment outcomes (all <i>p</i> values < 0.05), with odds ratios of 13.6200 (1.7285-107.3201), 7.1262 (1.3294-38.1997), and 14.8340 (1.1577-190.0784), respectively. Varied virulence factor mutations and virulence factor-related gene mutations exist across different <i>M. tuberculosis</i> lineages. Mutations in the espE, fadE29, and mbtI genes are risk factors that significantly affect the treatment outcome of Lineage2 patients. This finding serves as a reference for investigating the future evolutionary direction, transmissibility, drug resistance, and pathogenicity of <i>M. tuberculosis</i> virulence factors in regions with diverse lineages and frequent population movements.

VirulenceVol. 16(1)
Xinjiang Medical University (CN), Taiwan Centers for Disease Control (TW)
Openalex Percentile: Top 70%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.